RedStroke- Reducing Europe's stroke incidence: Highly cost-effective population screening programs for Atrial Fibrillation coupled with high diagnostic yield confirmation services.;Multicentre, international, investigator-initiated, controlled, randomised, double-blind clinical validation study of a smartphone application as screening tool for differentiation between sinus rhythm and atrial fibrillatio
Recruiting
- Conditions
- Artrial fibrillation10007521
- Registration Number
- NL-OMON52879
- Lead Sponsor
- niversity Hospital Basel ( Switserland)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
signed informed consent
• CHA2DS2-VASc score * 3, if patients less than 65 years old
• CHA2DS2-VASc score * 2, if patients 65 years or more
Exclusion Criteria
• history of AF
• current anticoagulation treatment,
• cardiac implanted electronic device (ICD or/and PM)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint of this study is the prevalence of AF confirmed by ECG in<br /><br>the app group compared with the standard care group</p><br>
- Secondary Outcome Measures
Name Time Method <p>The main secondary study outcomes are costs related to the AF screening with<br /><br>the app and the compliance in each study group </p><br>